Retrospective analysis of variation in heavy menstrual bleeding treatments by age and underlying cause

Current Medical Research and Opinion

Volumn 29, Issue 2, 2013, Pages 127-139

  Copher, Ronda ^a   Le Nestour, Elisabeth ^b   Law, Amy ^c   Pocoski, Jennifer ^c   Zampaglione, Edio ^c  

^a OPTUM   (United States)

^b PharmaNet/i3   (France)

^c Bayer HealthCare Pharmaceuticals Inc   (United States)

Author keywords

Excessive menstrual bleeding; Hypermenorrhea; Menorrhagia; Outcomes; Treatment patterns

Indexed keywords

CONTRACEPTIVE AGENT; ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; TRANEXAMIC ACID;

ANALYSIS OF VARIANCE; ARTICLE; CONTRACEPTION; DATA BASE; DRUG MEGADOSE; ENDOMETRIUM ABLATION; FEMALE; GROUPS BY AGE; HEALTH INSURANCE; HUMAN; HYSTERECTOMY; INTERNATIONAL CLASSIFICATION OF DISEASES; MENORRHAGIA; MYOMECTOMY; PRESCRIPTION; RETROSPECTIVE STUDY; UTERINE ARTERY EMBOLIZATION; VAGINA RING;

ADOLESCENT; ADULT; DATABASES, FACTUAL; ENDOMETRIAL ABLATION TECHNIQUES; FEMALE; HUMANS; HYSTERECTOMY; INSURANCE CLAIM REVIEW; MENORRHAGIA; MIDDLE AGED; PROGESTERONE CONGENERS; RETROSPECTIVE STUDIES; UNITED STATES; UTERINE MYOMECTOMY; YOUNG ADULT;

EID: 84872229468     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2012.759096     Document Type: Article

References (28)

1. Halberg L, Hogdahl AM, Nilsson L, et al. Menstrual blood loss-a population study. Acta Obstet Gynecol Scand 1966;45:320-51
2. Warner PE, Critchley HO, Lumsden MA, et al. Menorrhagia II: is the 80-mL blood loss criterion useful in management of complaint of menorrhagia? Am J Obstet Gynecol 2004;190:1224-9
3. Warner PE, Critchley HO, Lumsden MA, et al. Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data. Am J Obstet Gynecol 2004;190:1216-23
4. Lukes AS, Moore KA, Muse KN, et al. Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial. Obstet Gynecol 2010;116:865
5. Lukes AS, Muse K, Richter HE, et al. Estimating a meaningful reduction in menstrual blood loss for women with heavy menstrual bleeding. Curr Med Res Opin 2010;26:2673-8
6. Kouides PA. Menorrhagia from a haematologist's point of view. Part I: initial evaluation. Haemophilia 2002;8:330-8
7. Fraser IS, Critchley HO, Munro MG. Abnormal uterine bleeding: getting our terminology straight. Curr Opin Obstet Gynecol 2007;19:591-5
8. Woolcock JG, Critchley HO, Munro MG, et al. Review of the confusion in current and historical terminology and definitions for disturbances of menstrual bleeding. Fertil Steril 2008;90:2269-80
9. de Souza SS, Camargos AF, Ferreira MCF, et al. Hemoglobin levels predict quality of life in women with heavy menstrual bleeding. Arch Gynecol Obstet 2010;281:895-900
10. Byams VR. Women with bleeding disorders. J Womens Health (Larchmt) 2007;16:1249-51
11. Matteson KA, Clark MA. Questioning our questions: do frequently asked questions adequately cover the aspects of women's lives most affected by abnormal uterine bleeding? Opinions of women with abnormal uterine bleeding participating in focus group discussions. Womens Health 2010;50:195-211
12. Marret H, Fauconnier A, Chabbert-Buffet N, et al. Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause. Eur J Obstet Gynecol Reprod Biol 2010;152:133-7
13. Huchon C, Fritel X. Epidemiology of menometrorrhagia. J Gynecol Obstet Biol Reprod (Paris) 2008;37(Suppl 8):S307-16
14. Hurskainen R, Grenman S, Komi I, et al. Diagnosis and treatment of menorrhagia. Acta Obstet Gynecol Scand 2007;86:749-57
15. Grimes D, Davis A, Ramos D. Heavy menstrual bleeding: assessing impact, evaluating management options. Monograph. 2009. Available at: http://www.mycme.com/heavy-menstrual-bleedingassessing-impactevaluating- management-options/activity/143/(last accessed: 6 December 2012
16. Gitkind AI, Shah B, Thomas M. Epidural corticosteroid injections as a possible cause of menorrhagia: a case report. Pain Med 2010;11:713-15
17. Hickey M, Karthigasu K, Agarwal S. Abnormal uterine bleeding: a focus on polycystic ovary syndrome. Womens Health (Lond Engl) 2009;5:313-24
18. Munro MG, Critchley HO, Broder MS, et al. Disorders FWgoM. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet 2011;113:3-13
19. Rodeghiero F. Management of menorrhagia in women with inherited bleeding disorders: general principles and use of desmopressin. Haemophilia 2008;14(Suppl 1):21-30
20. Fraser IS, Healy DL, Torode H, et al. Depot goserelin and danazol pre-treatment before rollerball endometrial ablation for menorrhagia. Obstet Gynecol 1996;87:544-50
21. American College of Obstetricians and Gynecologists. Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Vol 1102010
22. Health Insurance Portability and Accountability Act of 1996. Public law 104-191, Available at http:/www.cms.hhs.gov/HIPAAGenInfo/Downloads/HIPAALaw.pdf (last accessed: 6 December 2012
23. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987;40:373-83
24. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130-9
25. Matteson KA, Boardman LA, Munro MG, Clark MA. Abnormal uterine bleeding: a review of patient-based outcome measures. Fertil Steril 2009;92:205-16
26. Homer H, Saridogan E. Uterine artery embolization for fibroids is associated with an increased risk of miscarriage. Fertil Steril 2010;94:324-30
27. Lethaby A, Augood C, Duckitt K, et al. Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev 2007, Issue 4. Art. No.: CD000400. DOI:10.1002/14651858.CD000400.pub2
28. Lukes AS, Baker J, Eder S, et al. Daily menstrual blood loss and quality of life in women with heavy menstrual bleeding. Womens Health (Lond Engl) 2012;8:503-11